Publication | Open Access
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
16
Citations
15
References
2019
Year
Use of liraglutide was associated with significantly lower risk of MACE and death in patients with type 2 diabetes and high cardiovascular risk using basal insulin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1